Loading…
Twist Bioscience Corporation is projected to rise to $144.64 by 2027, a +60% move from its current price of $90.64. TWST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $87.35 | $90.64 | $94.05 | 0.00% |
| Jul 14 | $86.02 | $90.64 | $95.51 | +0.01% |
| Jul 15 | $85.02 | $90.65 | $96.64 | +0.01% |
| Jul 16 | $84.19 | $90.65 | $97.61 | +0.02% |
| Jul 17 | $83.46 | $90.66 | $98.47 | +0.02% |
| Jul 18 | $82.81 | $90.66 | $99.26 | +0.03% |
| Jul 19 | $82.21 | $90.66 | $99.98 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $82.21 | $90.66 | $99.98 | +0.03% |
| Week 2 | $78.97 | $90.69 | $104.15 | +0.07% |
| Week 3 | $76.58 | $90.72 | $107.48 | +0.10% |
| Week 4 | $74.62 | $90.75 | $110.37 | +0.13% |
| Week 5 | $72.94 | $90.78 | $112.98 | +0.16% |
| Week 6 | $71.46 | $90.81 | $115.41 | +0.20% |
| Week 7 | $70.12 | $90.84 | $117.68 | +0.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs.
It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution.
The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Twist Bioscience Corporation (TWST) is a healthcare stock with a current price of $91.03 and a market cap of $5.67B.
It ranks 1290.
The multi-year forecast shows a bullish price trajectory, with the avg price projected to rise to $242.25 by 2030 and to $1,502.41 by 2050, with notable milestones along the way including 2030 avg $242.25; 2040 avg $772.25; 2050 avg $1,502.41.
Total potential returns increase across years, with ROI reaching 166.1 in 2030, 748.3 in 2040, and 1550.5 in 2050.
A major floor 53.6% below — a decisive break under it would weaken the trend.
The nearest floor, 26.2% below — buyers have tended to step in here.
The nearest ceiling, 13.5% above — a clean break opens room to run.
A major ceiling 35.5% above — clearing it would confirm fresh momentum.
Key TWST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TWST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $92.93 | Sell | $92.90 | Sell |
| MA 10 | $96.72 | Sell | $93.29 | Sell |
| MA 20 | $90.59 | Buy | $89.29 | Buy |
| MA 50 | $72.85 | Buy | $77.22 | Buy |
| MA 100 | $61.61 | Buy | $65.75 | Buy |
| MA 200 | $47.98 | Buy | $54.78 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.74 | Neutral |
| Stoch RSI (14) | 0.85 | Buy |
| CCI (20) | 0.49 | Neutral |
| Williams %R (14) | -68.46 | Info |
| MACD (12,26,9) | -1.46 | Sell |
| ROC (12) | 6.64 | Buy |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 31.54 | Neutral |
| TRIX (15) | 1.53 | Buy |
| Awesome (5,34) | 11.83 | Buy |
| Ultimate (7,14,28) | 37.22 | Neutral |
| Momentum (10) | -6.01 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 88.85 | Buy |
| ADX (14) | 34.09 | Buy |
| ATR (14) | 3.12 | Info |
The near-term technical picture is BULLISH. RSI14 is 60.
The stock trades above its SMA50 of $71.00 and above its SMA200 of $47.03, signaling an uptrend.
Near-term support is $60.57 and resistance is $102.88; the 30-day range is $70.68 to $117.24.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.39 | $90.64 | $133.27 | 0% | Neutral | |
| $111.36 | $144.64 | $200.85 | +60% | Bullish | |
| $139.69 | $188.70 | $274.83 | +108% | Bullish | |
| $146.61 | $204.67 | $309.31 | +126% | Bullish | |
| $167.00 | $240.07 | $374.17 | +165% | Bullish | |
| $174.86 | $258.23 | $413.40 | +185% | Bullish | |
| $176.88 | $267.91 | $439.25 | +196% | Bullish | |
| $222.80 | $345.64 | $579.03 | +281% | Bullish | |
| $280.31 | $444.94 | $760.21 | +391% | Bullish | |
| $309.66 | $502.50 | $874.37 | +454% | Bullish | |
| $435.15 | $782.22 | $1,468.23 | +763% | Bullish | |
| $706.30 | $1,528.43 | $3,197.99 | +15.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $32.39 | $90.64 | $111.82 | +0.00% |
| August 2026 | $78.31 | $93.31 | $114.80 | +2.95% |
| September 2026 | $75.66 | $91.02 | $113.65 | -2.46% |
| October 2026 | $78.37 | $95.06 | $120.18 | +4.44% |
| November 2026 | $83.55 | $102.06 | $130.37 | +7.37% |
| December 2026 | $84.05 | $103.34 | $133.27 | +1.25% |
Click any year to see its month-by-month TWST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TWST is projected to trade between $32.39 and $133.27, averaging $90.64 — a potential gain of 0% from today's $90.64. A consolidation phase looks the most probable path here.
Twist Bioscience Corporation's 2027 outlook centres on $144.64, within a $111.36 to $200.85 range. That is up +60% on the projected 2026 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2028, TWST could reach as high as $274.83, with a base case around $188.70 and support toward $139.69 — roughly +108% from $90.64. Buyers look set to stay in control over this stretch.
Expect TWST to range from $146.61 to $309.31 through 2029. The $204.67 average target implies a +126% move from current prices. That is up +8% on the projected 2028 average. Momentum favours further upside here.
The TWST price prediction for 2030 points to an average of $240.07 (low $167.00, high $374.17) — a potential gain of +165% on today's $90.64. Buyers look set to stay in control over this stretch.
In 2031, TWST is projected to trade between $174.86 and $413.40, averaging $258.23 — a potential gain of +185% from today's $90.64. That is up +8% on the projected 2030 average. Momentum favours further upside here.
Twist Bioscience Corporation's 2032 outlook centres on $267.91, within a $176.88 to $439.25 range. That is up +4% on the projected 2031 average. That marks a +196% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TWST could reach as high as $579.03, with a base case around $345.64 and support toward $222.80 — roughly +281% from $90.64. Momentum favours further upside here.
Expect TWST to range from $280.31 to $760.21 through 2034. The $444.94 average target implies a +391% move from current prices. That is up +29% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TWST price prediction for 2035 points to an average of $502.50 (low $309.66, high $874.37) — a potential gain of +454% on today's $90.64. Momentum favours further upside here.
In 2040, TWST is projected to trade between $435.15 and $1,468.23, averaging $782.22 — a potential gain of +763% from today's $90.64. That is up +56% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Twist Bioscience Corporation's 2050 outlook centres on $1,528.43, within a $706.30 to $3,197.99 range. That is up +95% on the projected 2040 average. That marks a +15.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in TWST today (≈ 11.033265 TWST) could be worth
$16,863.6
+$15,863.6 (+1586%) by 2050 · US Dollar
Based on the average projected TWST price of $1,528.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TWSTwould be worth at today's price.
$1,000 invested in TWST on Jul 10, 2025 (≈ 25.99428 TWST) would be worth
$2,355.99
+$1,355.99 (+135.6%) today · 2.36× · US Dollar
Based on a TWST entry price of $38.47 vs. today's $90.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $99.24 | $913.29 | -8.7% |
| 1 month ago | $67.77 | $1,337.39 | +33.7% |
| 3 months ago | $47.91 | $1,891.78 | +89.2% |
| 6 months ago | $38.04 | $2,382.62 | +138.3% |
| 1 year ago | $38.47 | $2,355.99 | +135.6% |
| All time (5.0y) ago | $120.28 | $753.53 | -24.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TWST forecast.
Our base-case forecast reaches $180.00 around 2028.
Implied market cap at $180.00: $11.21B
The multi-year forecast points to a persistent bullish trajectory, with meaningful upside through 2030, 2040, and 2050. The 2030 average is $242.25 with ROI 166.1; the 2040 average is $772.25 with ROI 748.3; and the 2050 average is $1,502.41 with ROI 1550.5.
In the near term, 2026 shows min $32.39, avg $91.03, max $133.90 with ROI 0 and sentiment NEUTRAL, followed by 2027 min $111.34, avg $145.39, max $203.29 with ROI 59.7 and sentiment BULLISH.
These figures are estimates and not guarantees; actual results may vary based on market conditions and other factors.
Tap a question to reveal the answer.
Avg price $242.25, with a min of $166.86 and a max of $381.35, ROI 166.1, sentiment BULLISH.
The forecast shows a transition from Neutral in 2026 (avg $91.03, min $32.39, max $133.90, ROI 0) to Bullish in 2027 (avg $145.39, min $111.34, max $203.29, ROI 59.7). Longer term, strong upside is projected to 2030, 2040, and 2050.
Yes. The 2026 max is $133.90, and the 2027 forecast has an avg of $145.39 with a max of $203.29, indicating it could exceed $100 in 2026 or 2027.
Avg price $772.25, min $420.33, max $1,470.71, ROI 748.3, sentiment BULLISH.
Avg price $1,502.41, min $676.09, max $3,196.94, ROI 1550.5, sentiment BULLISH.
Twist Bioscience Corporation Community Discussion
0Share your Twist Bioscience Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.